CompletedNCT03621007
An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes
Studying Obesity due to pro-opiomelanocortin deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Principal Investigator
- Murray Stewart, MDRhythm Pharmceuticals, Inc
- Enrollment
- 8 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2019 – 2021
Study locations (3)
- Dokuz Eylul Universitesi Tip Fakultesi, Balçova, Turkey (Türkiye)
- Ege University School of Medicine of Pediatric Endocrinology, Bornova, Turkey (Türkiye)
- Pediatric Endocrinology and Diabetes Marmara University Hospital, Istanbul, Turkey (Türkiye)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03621007 on ClinicalTrials.gov